Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency
- 8 February 2016
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 31 (3) , 352-359
Abstract
Background: Dementia is a common feature of Parkinson's disease (PD), but the neuropathological changes associated with the development of Parkinson's disease dementia (PDD) are only partially understood. Mitochondrial dysfunction is a hallmark of PD but has not been studied in PDD.Methods: Molecular and biochemical approaches were used to study mitochondrial activity and quantity in postmortem prefrontal cortex tissue. Tissues from pathologically confirmed PD and PDD patients and from age‐matched controls were used to analyze the activity of mitochondrial enzyme complex nicotinamide adenine dinucleotide:ubiquinone oxidoreductase, or complex I (the first enzyme in the mitochondrial respiratory chain), mitochondrial DNA levels, and the expression of mitochondrial proteins.Results: Complex I activity was significantly decreased (27% reduction; analysis of variance with Tukey's post hoc test; P < 0.05) in PDD patients, and mitochondrial DNA levels were also significantly decreased (18% reduction; Kruskal‐Wallis analysis of variance with Dunn's multiple comparison test; P < 0.05) in PDD patients compared with controls, but neither was significantly reduced in PD patients. Overall, mitochondrial biogenesis was unaffected in PD or PDD, because the expression of mitochondrial proteins in patients was similar to that in controls.Conclusions: Patients with PDD have a deficiency in mitochondrial complex I activity and reduced mitochondrial DNA levels in the prefrontal cortex without a change in mitochondrial protein quantity. Therefore, mitochondrial complex I deficiency and reduced mitochondrial DNA in the prefrontal cortex may be a hallmark of dementia in patients with PD. © 2016 International Parkinson and Movement Disorder SocietyKeywords
This publication has 45 references indexed in Scilit:
- Direct detection of alpha synuclein oligomers in vivoActa Neuropathologica Communications, 2013
- Impairment of Mitochondria in Adult Mouse Brain Overexpressing Predominantly Full-Length, N-Terminally Acetylated Human α-SynucleinPLOS ONE, 2013
- The Transgenic Overexpression of α-Synuclein and Not Its Related Pathology Associates with Complex I InhibitionJournal of Biological Chemistry, 2010
- Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundanceMolecular Neurodegeneration, 2009
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease BrainJournal of Biological Chemistry, 2008
- Protection by the NDI1 Gene against Neurodegeneration in a Rotenone Rat Model of Parkinson's DiseasePLOS ONE, 2008
- Complex I deficiency in Parkinson's disease frontal cortexBrain Research, 2008
- α-Synuclein expression in the substantia nigra of MPTP-lesioned non-human primatesNeurobiology of Disease, 2005
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Parkinson's Disease in a Chemist Working with 1-Methyl-4-Phenyl-L,2,5,6-TetrahydropyridineNew England Journal of Medicine, 1983